You are not logged in.
Please login to continue selecting trials.
Generic NameGolimumabProduct NameSIMPONI®Therapeutic AreaDigestive System DiseasesEnrollment103% Female44.7%% White89.3%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberCNTO148UCO2001Data PartnerJohnson & JohnsonCondition StudiedColitis, UlcerativeMean/Median Age (Years)42
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Validation of an artificial intelligence model on central read endoscopic disease severity in patients with ulcerative colitis
- Identification of the Need for Hematopoietic Stem Cell Transplantation in Crohn's Disease Patients: A Ma-chine Learning Approach
- Influence of Race and Ethnicity on the Efficacy of Biologic Drugs for Inflammatory Bowel Disease